ESCRS - Laser still the mainstay of macular oedema treatment ;
ESCRS - Laser still the mainstay of macular oedema treatment ;

Laser still the mainstay of macular oedema treatment

The parameters of laser photocoagulation have evolved in recent clinical studies

Laser still the mainstay of macular oedema treatment
Dermot McGrath
Dermot McGrath
Published: Monday, June 12, 2017

David Pelayes MD
While the introduction of anti-VEGF therapies is transforming the clinical management of diabetic macular oedema (DME), focal laser photocoagulation still remains the gold standard in the initial treatment of the disease, according to David Pelayes MD. "We now have more options thanks to anti-VEGF therapies, but focal laser is not going to disappear from our treatment arsenal. Reducing the side effects and improving the safety and efficacy of the therapy are some of the central aims of contemporary laser photocoagulation," he told delegates attending the European Society of Ophthalmology (SOE) 2017 Congress in Barcelona, Spain. Dr Pelayes, Full Professor of Ophthalmology, Buenos Aires University, Argentina, and Full Professor of Ophthalmology, Maimonides University, noted that the parameters of laser photocoagulation have evolved in recent clinical studies by incorporating shorter pulse durations and lower laser energy. "Clinical trials have demonstrated that lower energy can reduce side effects and risks while effectively alleviating DME," he said.
Clinical trials have demonstrated that lower energy can reduce side effects and risks while effectively alleviating DME
The general macular settings for the laser now include an exposure time of 10 to 20 milliseconds, resulting in sharply decreased energy density and thermal diffusion, he explained. "Furthermore, studies have shown that the retinal photocoagulation induced by 10 to 30 ms exposure time can stimulate inner retinal healing responses and is associated with less destructive effects than traditional methods," he said.
Tags: macular oedema, retina
Latest Articles
From Lab to Life: Corneal Repair Goes Cellular

Long-awaited cellular therapies for corneal endothelial disease enter the clinic.

Read more...

Balancing Innovation and Safety

Ensuring access to advanced cell therapies amid regulatory overhaul.

Read more...

With Eyes on Its Future, ESCRS Celebrates Its Past

Winter Meeting offers opportunities to experiment with new concepts and formats.

Read more...

Piecing Together a Solution

What is the best use of robotics and AI in cataract and refractive surgery?

Read more...

Advances in Toric IOL Alignment

Biomorphometric approaches offer high precision and increase efficiency.

Read more...

Library of Short Videos Complements Educational Offerings

Read more...

Tackling Waste in Retinal Surgery

Reducing waste from intravitreal injections is an achievable goal.

Read more...

The Modern Era of Refractive Surgery

New technologies for screening and treatment qualify more patients for intervention.

Read more...

Monofocal Plus Finding the Balance

Enhanced monofocals may be the future standard of care in cataract patients.

Read more...

Growing Options Optimise Outcomes in Cataract Surgery

Understanding the promise and potential problems of AI-based IOL formulas.

Read more...

;